Affiliation:
1. Center for Drug Safety Evaluation and Research, State Key Laboratory of Drug Research Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai China
2. School of Pharmacy University of Chinese Academy of Sciences Beijing China
3. School of Chinese Materia Medica Nanjing University of Chinese Medicine Nanjing China
4. Department of Pharmaceutics, School of Pharmacy Shenyang Pharmaceutical University Shenyang China
Abstract
AbstractBackgroundExcessive fatty acids in the liver lead to the accumulation of lipotoxic lipids and then cellular stress to further evoke the related disease, like non‐alcoholic fatty liver disease (NAFLD). As reported, fatty acid stimulation can cause some specific miRNA dysregulation, which caused us to investigate the relationship between miRNA biogenesis and fatty acid overload.MethodsGene expression omnibus (GEO) dataset analysis, miRNA‐seq, miRNA cleavage assay, RT‐qPCR, western blotting, immunofluorescence and co‐immunoprecipitation (co‐IP) were used to reveal the change of miRNAs under pathological status and explore the relevant mechanism. High fat, high fructose, high cholesterol (HFHFrHC) diet‐fed mice transfected with AAV2/8‐shDrosha or AAV2/8‐shPRMT5 were established to investigate the in vivo effects of Drosha or PRMT5 on NAFLD phenotype.ResultsWe discovered that the cleavage of miRNAs was inhibited by analysing miRNA contents and detecting some representative pri‐miRNAs in multiple mouse and cell models, which was further verified by the reduction of the Microprocessor activity in the presence of palmitic acid (PA). In vitro, PA could induce Drosha, the core RNase III in the Microprocessor complex, degrading through the proteasome‐mediated pathway, while in vivo, knockdown of Drosha significantly promoted NAFLD to develop to a more serious stage. Mechanistically, our results demonstrated that PA can increase the methyltransferase activity of PRMT5 to degrade Drosha through MDM2, a ubiquitin E3 ligase for Drosha. The above results indicated that PRMT5 may be a critical regulator in lipid metabolism during NAFLD, which was confirmed by the knocking down of PRMT5 improved aberrant lipid metabolism in vitro and in vivo.ConclusionsWe first demonstrated the relationship between miRNA dosage and NAFLD and proved that PA can activate the PRMT5‐MDM2‐Drosha signalling pathway to regulate miRNA biogenesis.
Funder
National Natural Science Foundation of China
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献